173 related articles for article (PubMed ID: 37151881)
21. WWP1 E3 ligase targets LATS1 for ubiquitin-mediated degradation in breast cancer cells.
Yeung B; Ho KC; Yang X
PLoS One; 2013; 8(4):e61027. PubMed ID: 23573293
[TBL] [Abstract][Full Text] [Related]
22. Interaction of S100A1 with LATS1 promotes cell growth through regulation of the Hippo pathway in hepatocellular carcinoma.
Guo Q; Wang J; Cao Z; Tang Y; Feng C; Huang F
Int J Oncol; 2018 Aug; 53(2):592-602. PubMed ID: 29901195
[TBL] [Abstract][Full Text] [Related]
23. S100A16 suppresses the growth and survival of leukaemia cells and correlates with relapse and relapse free survival in adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia.
Zhang J; Lu WY; Zhang JM; Lu RQ; Wu LX; Qin YZ; Liu YR; Lai YY; Jiang H; Jiang Q; Jiang B; Xu LP; Zhang XH; Huang XJ; Ruan GR; Liu KY
Br J Haematol; 2019 Jun; 185(5):836-851. PubMed ID: 30916375
[TBL] [Abstract][Full Text] [Related]
24. ZNF143 facilitates the growth and migration of glioma cells by regulating KPNA2-mediated Hippo signalling.
Chen Y; Li J; Ma J; Bao Y
Sci Rep; 2023 Jul; 13(1):11097. PubMed ID: 37423952
[TBL] [Abstract][Full Text] [Related]
25. [S100 calcium binding protein A16 promotes fat synthesis through endoplasmic reticulum stress in HepG2 cells].
Kan JB; Shen GQ; Yang J; Tong P; Zhang RH; Liang XB; Su DM; Li D; Liu Y
Sheng Li Xue Bao; 2019 Apr; 71(2):279-286. PubMed ID: 31008487
[TBL] [Abstract][Full Text] [Related]
26. LATS1 K751 acetylation blocks activation of Hippo signalling and switches LATS1 from a tumor suppressor to an oncoprotein.
Yang S; Xu W; Liu C; Jin J; Li X; Jiang Y; Zhang L; Meng X; Zhan J; Zhang H
Sci China Life Sci; 2022 Jan; 65(1):129-141. PubMed ID: 33945069
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of microRNA-103a-3p inhibits the malignancy of thyroid cancer cells through Hippo signaling pathway by upregulating LATS1.
Zhang ML; Sun WH; Wu HQ; Liu ZD; Wang P
Neoplasma; 2020 Nov; 67(6):1266-1278. PubMed ID: 32749848
[TBL] [Abstract][Full Text] [Related]
28. WWC3 inhibits intimal proliferation following vascular injury via the Hippo signaling pathway.
Chen B; Liu G
Mol Med Rep; 2018 Apr; 17(4):5175-5183. PubMed ID: 29393412
[TBL] [Abstract][Full Text] [Related]
29. Paris saponin VII, a Hippo pathway activator, induces autophagy and exhibits therapeutic potential against human breast cancer cells.
Xiang YC; Peng P; Liu XW; Jin X; Shen J; Zhang T; Zhang L; Wan F; Ren YL; Yu QQ; Zhao HZ; Si Y; Liu Y
Acta Pharmacol Sin; 2022 Jun; 43(6):1568-1580. PubMed ID: 34522004
[TBL] [Abstract][Full Text] [Related]
30. ADAMTS19 Suppresses Cell Migration and Invasion by Targeting S100A16 via the NF-κB Pathway in Human Gastric Cancer.
Jiang Y; Yu X; Zhao Y; Huang J; Li T; Chen H; Zhou J; Huang Z; Yang Z
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33921267
[TBL] [Abstract][Full Text] [Related]
31. ADAM Metallopeptidase Domain 12 Facilitates Colorectal Cancer Progression by Inhibiting Hippo Signaling Pathway Activity.
Wang X; Zhu M; Zuo H; Hou G; Xie R
Mol Cancer Res; 2023 Jun; 21(6):525-534. PubMed ID: 36806444
[TBL] [Abstract][Full Text] [Related]
32. An Update on S100A16 in Human Cancer.
Basnet S; Vallenari EM; Maharjan U; Sharma S; Schreurs O; Sapkota D
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509106
[TBL] [Abstract][Full Text] [Related]
33. DNMT3B and TET1 mediated DNA methylation of LATS1 regulates BC progression via hippo signaling pathway.
Wu H; Jiao Y; Guo X; Wu Z; Lv Q
Pathol Res Pract; 2022 Dec; 240():154231. PubMed ID: 36413827
[TBL] [Abstract][Full Text] [Related]
34. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
Tanaka M; Ichikawa-Tomikawa N; Shishito N; Nishiura K; Miura T; Hozumi A; Chiba H; Yoshida S; Ohtake T; Sugino T
BMC Cancer; 2015 Feb; 15():53. PubMed ID: 25884418
[TBL] [Abstract][Full Text] [Related]
35. CUL4A promotes proliferation and inhibits apoptosis of colon cancer cells via regulating Hippo pathway.
Yi LJ; Yi LJ; Ding N; Ren J
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10518-10525. PubMed ID: 33155207
[TBL] [Abstract][Full Text] [Related]
36. S100A16 cooperates with DEPDC1 to promote the progression and angiogenesis of nephroblastoma through PI3K/Akt/mTOR pathway.
Geng G; Xu Y; Li Q; Li Q; Yuan L; Dong M; Ming M
Pol J Pathol; 2023; 74(3):182-193. PubMed ID: 37955537
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-6884-5p Regulates the Proliferation, Invasion, and EMT of Gastric Cancer Cells by Directly Targeting S100A16.
Lv H; Hou H; Lei H; Nie C; Chen B; Bie L; Han L; Chen X
Oncol Res; 2020 May; 28(3):225-236. PubMed ID: 31796150
[TBL] [Abstract][Full Text] [Related]
38. MPDZ as a novel epigenetic silenced tumor suppressor inhibits growth and progression of lung cancer through the Hippo-YAP pathway.
Liu W; Huang Y; Wang D; Han F; Chen H; Chen J; Jiang X; Cao J; Liu J
Oncogene; 2021 Jul; 40(26):4468-4485. PubMed ID: 34108620
[TBL] [Abstract][Full Text] [Related]
39. The expression of S100A8/S100A9 is inducible and regulated by the Hippo/YAP pathway in squamous cell carcinomas.
Li Y; Kong F; Jin C; Hu E; Shao Q; Liu J; He D; Xiao X
BMC Cancer; 2019 Jun; 19(1):597. PubMed ID: 31208368
[TBL] [Abstract][Full Text] [Related]
40. A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway.
Bao L; Yuan L; Li P; Bu Q; Guo A; Zhang H; Cui N; Liu B
Cell Physiol Biochem; 2018; 50(2):437-451. PubMed ID: 30308519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
